Logo for Disc Medicine Inc

Disc Medicine Investor Relations Material

Latest events

Logo for Disc Medicine Inc

Study Update

Disc Medicine
Logo for Disc Medicine

Q4 2024

27 Feb, 2025
Logo for Disc Medicine

Study Update

21 Jan, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Disc Medicine Inc

Access all reports
Disc Medicine Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative treatments for severe hematologic disorders. Founded as Gemini Therapeutics Inc before evolving into its current form, the company has a pipeline that includes therapies aimed at erythropoietic porphyrias (including erythropoietic protoporphyria and X-linked protoporphyria), Diamond-Blackfan Anemia, anemia of myelofibrosis, chronic kidney disease, and polycythemia vera among others. Disc Medicine's preclinical programs also target anemia associated with inflammatory diseases. The company is headquartered in Watertown, Massachusetts, and its shares are listed on the NASDAQ.